Rigel Pharmaceuticals Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$35.73

+2.82 (+8.57%)

As of Jun 22, 10:02 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 8 73%

Hold 3 27%

Sell 0 0%

Price Target

Analyst Price Target +51.4% upside

Low Target $39.68

Average Target $54.10

High Target $74.39

Current Price $35.73

Current
$35.73

Target
$54.10

$39.68 $54.10 avg $74.39

Scenario Analysis

Bear Case

$39.68

11.1%

Low target

Base Case

$54.10

+51.4%

Avg target

Bull Case

$74.39

+108.2%

High target

Risk/Reward

9.8x

Highly favorable

Price in Context

52-Week High

$52.24

-31.6% from high

52-Week Low

$18.14

+97.0% from low

Target vs 52W High

$54.10

+3.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%